{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:08:32Z","timestamp":1787065712241,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Advances in ultrasensitive immunoassays have enabled reliable quantification of neuroglial biomarkers in blood, providing valuable insights into neurological disorders. However, cross-platform evaluations are necessary to ensure comparability and standardization. This study aimed to compare the analytical performance of a Single Molecule Array (Simoa) and an ultrasensitive electrochemiluminescence (ECL) assay for quantifying neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) in human serum. Baseline serum samples from 174 participants in the RIFUND trial were analyzed in parallel on both platforms. Concentrations of NfL and GFAP were compared using Spearman correlation, Bland\u2013Altman analyses, reproducibility assessments, dilution linearity, and cross-platform recovery. All samples were quantifiable on both platforms. NfL concentrations correlated strongly between methods (Spearman correlation\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.88,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001), whereas GFAP correlated moderately (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.77,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Inter- and intra-assay coefficients of variation were comparable between platforms for both analytes. The relationship between the two assays could be described with the following equations: NfL\n                    <jats:sub>ECL<\/jats:sub>\n                    \u2009=\u20097.63\u2009\u00d7\u2009NfL\n                    <jats:sub>SIMOA<\/jats:sub>\n                    \u2009+\u20091.71 and GFAP\n                    <jats:sub>ECL<\/jats:sub>\n                    \u2009=\u20090.332\u2009\u00d7\u2009GFAP\n                    <jats:sub>SIMOA<\/jats:sub>\n                    \u2009+\u20094.22. Dilution linearity was excellent on both platforms (R\n                    <jats:sup>2<\/jats:sup>\n                    \u2009&gt;\u20090.99), although cross-platform recovery varied systematically across the analytical range. Both Simoa and ECL demonstrated strong analytical performance for neuroglial biomarker quantification in serum. Despite systematic differences in absolute concentrations, relative agreement was high, particularly for NfL. These findings highlight the need for platform harmonization and provide empirically derived conversion factors to support analytical comparability in research and clinical applications.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-56794-x","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:09:21Z","timestamp":1782853761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of two analytical platforms for quantification of neuroglial biomarkers in blood samples: a single molecule array and an electrochemiluminescence assay"],"prefix":"10.1038","volume":"16","author":[{"given":"Julia","family":"Aulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Al-Grety","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Sj\u00f6lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Erngren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Svenningsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Kultima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Burman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"6","key":"56794_CR1","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1021\/ac103161b","volume":"83","author":"DM Rissin","year":"2011","unstructured":"Rissin, D. M. et al. Simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic range. Anal. Chem. 83(6), 2279\u20132285. https:\/\/doi.org\/10.1021\/ac103161b (2011).","journal-title":"Anal. Chem."},{"issue":"4","key":"56794_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1080\/10408363.2019.1700903","volume":"57","author":"C Wu","year":"2019","unstructured":"Wu, C., Maley, A. M. & Walt, D. R. Single-molecule measurements in microwells for clinical applications. Crit. Rev. Clin. Lab. Sci. 57(4), 270\u2013290. https:\/\/doi.org\/10.1080\/10408363.2019.1700903 (2019).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"10","key":"56794_CR3","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1039\/c5cs00086f","volume":"44","author":"Z Liu","year":"2015","unstructured":"Liu, Z., Qi, W. & Xu, G. Recent advances in electrochemiluminescence. Chem. Soc. Rev. 44(10), 3117\u20133142. https:\/\/doi.org\/10.1039\/c5cs00086f (2015).","journal-title":"Chem. Soc. Rev."},{"key":"56794_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jim.2018.12.005","volume":"466","author":"J Poorbaugh","year":"2019","unstructured":"Poorbaugh, J. et al. Measurement of IL-21 in human serum and plasma using ultrasensitive MSD S-PLEX\u00ae and Quanterix SiMoA methodologies. J. Immunol. Methods. 466, 9\u201316. https:\/\/doi.org\/10.1016\/j.jim.2018.12.005 (2019).","journal-title":"J. Immunol. Methods."},{"issue":"4","key":"56794_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215443","volume":"14","author":"T Broger","year":"2019","unstructured":"Broger, T. et al. Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients. PLoS ONE 14(4), e0215443. https:\/\/doi.org\/10.1371\/journal.pone.0215443 (2019).","journal-title":"PLoS ONE"},{"issue":"8","key":"56794_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S1474-4422(22)00209-5","volume":"21","author":"A Svenningsson","year":"2022","unstructured":"Svenningsson, A. et al. Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: A rater-blinded, phase 3, randomised controlled trial. Lancet. Neurol. 21(8), 693\u2013703. https:\/\/doi.org\/10.1016\/S1474-4422(22)00209-5 (2022).","journal-title":"Lancet. Neurol."},{"key":"56794_CR7","doi-asserted-by":"crossref","unstructured":"Wechsler, S. Statistics at Square One. Statistics in sMedicine. 1997, Ninth Edition, revised by M. J. Campbell, T. D. V. Swinscow, 2629\u20132630 (BMJ Publ. Group, London, 1996).","DOI":"10.1002\/(SICI)1097-0258(19971130)16:22<2629::AID-SIM698>3.0.CO;2-Z"},{"issue":"28","key":"56794_CR8","doi-asserted-by":"publisher","first-page":"11433","DOI":"10.1021\/acs.analchem.2c01666","volume":"94","author":"S Zhou","year":"2022","unstructured":"Zhou, S. et al. Electrochemical quantitation of the glycosylation level of serum neurofilament light chain for the diagnosis of neurodegeneration: An interface-solution dual-path amplification strategy. Anal. Chem. 94(28), 11433\u201311440. https:\/\/doi.org\/10.1021\/acs.analchem.2c01666 (2022).","journal-title":"Anal. Chem."},{"key":"56794_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1759091420949680","volume":"0","author":"A Messing","year":"2020","unstructured":"Messing, A. & Brenner, M. GFAP at 50. ASN Neuro 0, 1\u201323. https:\/\/doi.org\/10.1177\/1759091420949680 (2020).","journal-title":"ASN Neuro"},{"issue":"1","key":"56794_CR10","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2022-1194","volume":"61","author":"L Li","year":"2022","unstructured":"Li, L. et al. Diagnostic utility of total NT-proBNP testing by immunoassay based on antibodies targeting glycosylation-free regions of NT-proBNP. Clin. Chem. Lab. Med. 61(1), e1194. https:\/\/doi.org\/10.1515\/cclm-2022-1194 (2022).","journal-title":"Clin. Chem. Lab. Med."},{"key":"56794_CR11","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2025-0610","author":"U Sheth","year":"2025","unstructured":"Sheth, U. et al. Measuring neurofilament light in human plasma and cerebrospinal fluid: A comparison of five analytical immunoassays. Clin. Chem. Lab. Med. https:\/\/doi.org\/10.1515\/cclm-2025-0610 (2025) (aop).","journal-title":"Clin. Chem. Lab. Med."},{"issue":"11","key":"56794_CR12","doi-asserted-by":"publisher","first-page":"8216","DOI":"10.1002\/alz.14184","volume":"20","author":"MM Mielke","year":"2024","unstructured":"Mielke, M. M. et al. Recommendations for clinical implementation of blood-based biomarkers for Alzheimer\u2019s disease. Alzheimers. Dement. 20(11), 8216\u20138224. https:\/\/doi.org\/10.1002\/alz.14184 (2024).","journal-title":"Alzheimers. Dement."},{"issue":"10","key":"56794_CR13","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","volume":"54","author":"J Kuhle","year":"2016","unstructured":"Kuhle, J. et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin. Chem. Lab. Med. 54(10), 1655\u20131661. https:\/\/doi.org\/10.1515\/cclm-2015-1195 (2016).","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"56794_CR14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/ijms26020831","volume":"26","author":"AD Remnitz","year":"2025","unstructured":"Remnitz, A. D., Hadad, R., Keane, R. W., Dietrich, W. D. & de Rivero Vaccari, J. P. Comparison of methods of detecting il-1beta in the blood of alzheimer\u2019s disease subjects. Int. J. Mol. Sci. 26(2), 831. https:\/\/doi.org\/10.3390\/ijms26020831 (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"S2","key":"56794_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/alz.091850","volume":"20","author":"HA Fatima","year":"2024","unstructured":"Fatima, H. A. et al. Clinical evaluation of a plasma neurofilament light chain electrochemiluminescence immunoassay in Alzheimer\u2019s disease. Alzheimers. Dement. 20(S2), e091850. https:\/\/doi.org\/10.1002\/alz.091850 (2024).","journal-title":"Alzheimers. Dement."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56794-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56794-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56794-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:55:56Z","timestamp":1782856556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56794-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56794"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56794-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19939"}}